Rising APAC Device MnA Demonstrates The Need For Regulatory Strategy
This article was originally published in SRA
Executive Summary
The number of M&A deals across Asia Pacific is increasing rapidly. But demonstration of product regulatory compliance is often not transferrable between APAC countries. How do you overcome this and other regulatory hurdles during your M&A deal-making? In this article, Ee Von Teo and Daniel Tan, together with their colleagues*, explain how to manage this dynamic new market opportunity. They also give a breakdown of the different medical device regulatory regimes in APAC and the transferability of registrations and licences by individual countries.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.